MENU
ANEB
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Anebulo Pharmaceuticals (ANEB) Ownership - Who owns Anebulo Pharmaceuticals?

Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing treatments for cannabinoid overdose and substance addiction... Show more

Profile

Industry
N/A
Address
1017 Ranch Road 620 South
Phone
+1 512 598-0931
Employees
2
Web
https://www.anebulo.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
94.08M
P/E Ratio
N/A
Total Cash
10.35M
Projected Growth
N/A
Total Debt
N/A
Revenue
N/A
Risk (Beta)
-0.36
Dividend Yield
N/A
Total Cash/Share
0.25
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price

Fundamentals

ANEB
Capitalization
94.1M
P/E Ratio
N/A
Risk (Beta)
-0.36
Dividend Yield
N/A
Total Cash
10.4M
Total Cash/Share
0.25
Total Debt
N/A
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
9.74M
P/B Ratio
9.66
Cash Flow
N/A
Earnings
-0.22
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
41.1K
Current Ratio
10.93
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-8.1M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-128.22
Shares Held By Institutions
55.8M
Shares Outstanding - Current
41.1M
Total Liabilities
964K
Total Volume MTD
N/A
Value
N/A
Gain YTD
33.333
View a ticker or compare two or three
ANEB
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ANEB showed earnings on November 13, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
1017 Ranch Road 620 South
Phone
+1 512 598-0931
Employees
2
Web
https://www.anebulo.com